ATE277042T1 - Antimikrobielle 4-oxochinolizine mit 2- pyridongerüsten als teilstruktur - Google Patents

Antimikrobielle 4-oxochinolizine mit 2- pyridongerüsten als teilstruktur

Info

Publication number
ATE277042T1
ATE277042T1 AT00969876T AT00969876T ATE277042T1 AT E277042 T1 ATE277042 T1 AT E277042T1 AT 00969876 T AT00969876 T AT 00969876T AT 00969876 T AT00969876 T AT 00969876T AT E277042 T1 ATE277042 T1 AT E277042T1
Authority
AT
Austria
Prior art keywords
group
hydrogen atom
amino
oxochinolizine
pyridone
Prior art date
Application number
AT00969876T
Other languages
English (en)
Inventor
Ryoichi Fukumoto
Hiroyuki Kusakabe
Chong Chu
Hiroaki Kimura
Satoshi Yanagihara
Masatoshi Kato
Chisato Hirosawa
Seiji Ishiduka
Fusae Shizume
Original Assignee
Sato Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sato Pharma filed Critical Sato Pharma
Application granted granted Critical
Publication of ATE277042T1 publication Critical patent/ATE277042T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT00969876T 1999-10-19 2000-10-19 Antimikrobielle 4-oxochinolizine mit 2- pyridongerüsten als teilstruktur ATE277042T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29638399 1999-10-19
PCT/JP2000/007256 WO2001029035A1 (fr) 1999-10-19 2000-10-19 Antimicrobiens 4-oxoquinolizine presentant des squelettes 2-pyridone en tant que structure partielle

Publications (1)

Publication Number Publication Date
ATE277042T1 true ATE277042T1 (de) 2004-10-15

Family

ID=17832846

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00969876T ATE277042T1 (de) 1999-10-19 2000-10-19 Antimikrobielle 4-oxochinolizine mit 2- pyridongerüsten als teilstruktur

Country Status (8)

Country Link
US (1) US6525066B2 (de)
EP (1) EP1227096B1 (de)
JP (1) JP4328049B2 (de)
AT (1) ATE277042T1 (de)
AU (1) AU7948900A (de)
DE (1) DE60014143T2 (de)
ES (1) ES2225237T3 (de)
WO (1) WO2001029035A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2387016C (en) * 1999-10-08 2010-09-28 William H. Miller Acrylamide derivatives as fab i inhibitors
WO2002022614A1 (fr) * 2000-09-12 2002-03-21 Sankyo Company,Limited Derives de quinolizine
WO2003088897A2 (en) * 2001-04-06 2003-10-30 Affinium Pharmaceuticals, Inc. Fab i inhibitors
ATE404558T1 (de) * 2001-09-28 2008-08-15 Sato Pharma Antimikrobielle 4-oxochinolizinverbindungen, die als teilstruktur ein 2-pyridonskelett aufweisen
EP1575951B1 (de) * 2002-12-06 2014-06-25 Debiopharm International SA Heterozyclische verbindungen, verfahren zu deren herstellung und ihre verwendung als heilmittel
WO2004082586A2 (en) 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
WO2005019224A2 (en) * 2003-06-06 2005-03-03 Cadila Healthcare Limited Novel antiinfective compounds
PL1828167T3 (pl) * 2004-06-04 2015-02-27 Debiopharm Int Sa Pochodne akryloamidu jako środki antybiotykowe
WO2007067416A2 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
EP2054422B1 (de) 2006-07-20 2017-06-14 Debiopharm International SA Acrylamidderivate als fab-i-inhibitoren
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
EP3255045A1 (de) * 2007-02-16 2017-12-13 Debiopharm International SA Salze, prodrugs und polymorphe von fab i-inhibitoren
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
EP3034078A1 (de) 2010-09-27 2016-06-22 Emergent Product Development Gaithersburg Inc. Antimikrobielle 2-pyridon-zusammensetzungen
WO2012104305A1 (en) * 2011-02-01 2012-08-09 Evolva Sa Antimicrobial 4-oxoquinolizines
JP6085026B2 (ja) 2012-06-19 2017-02-22 デビオファーム インターナショナル エスエーＤｅｂｉｏｐｈａｒｍ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｓａ （ｅ）−ｎ−メチル−ｎ−（（３−メチルベンゾフラン−２−イル）メチル）−３−（７−オキソ−５，６，７，８−テトラヒドロ−１，８−ナフチリジン−３−イル）アクリルアミドのプロドラッグ誘導体
US10751351B2 (en) 2016-02-26 2020-08-25 Debiopharm International S.A. Medicament for treatment of diabetic foot infections
CN110938028B (zh) * 2019-12-09 2022-03-04 南京杰运医药科技有限公司 一种(1r)-5-溴-2,3-二氢-1-甲基-1h-异吲哚的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU689809B2 (en) * 1993-10-14 1998-04-09 Abbott Laboratories Quinolizinone type compounds
DK0775702T3 (da) 1994-08-12 2003-08-18 Toyama Chemical Co Ltd Hidtil ukendte quinolon- eller naphthylidoncarboxylsyrederivater eller salt deraf
JP3833738B2 (ja) 1995-11-15 2006-10-18 第一製薬株式会社 置換アミノメチルピロリジン誘導体
WO2002022614A1 (fr) * 2000-09-12 2002-03-21 Sankyo Company,Limited Derives de quinolizine

Also Published As

Publication number Publication date
WO2001029035A1 (fr) 2001-04-26
EP1227096B1 (de) 2004-09-22
US20020173517A1 (en) 2002-11-21
AU7948900A (en) 2001-04-30
US6525066B2 (en) 2003-02-25
EP1227096A4 (de) 2003-04-02
DE60014143D1 (de) 2004-10-28
ES2225237T3 (es) 2005-03-16
DE60014143T2 (de) 2006-03-02
JP4328049B2 (ja) 2009-09-09
EP1227096A1 (de) 2002-07-31

Similar Documents

Publication Publication Date Title
ATE277042T1 (de) Antimikrobielle 4-oxochinolizine mit 2- pyridongerüsten als teilstruktur
AP2002002603A0 (en) 3-aminoquinazolin-2,4-dione antibacterial agents.
BR9913097B1 (pt) Derivado heterocíclico de carboxamida contendo nitrogênio ou um sal do mesmo
PE20011348A1 (es) Agentes antivirales de imidazopiridina e imidazopimiridina
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
ATE392411T1 (de) Neue substituierte anilinderivate mit herbizider wirkung
MY132698A (en) Herbicidal composition
HUP9802822A2 (hu) Halogén-benzimidazol-származékok, intermedierjeik, előállításuk és a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények
ATE161257T1 (de) Azolylamin-derivat
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
DK1180519T3 (da) Hydrochlorid af en kondenseret heterocyklisk forbindelse
PH12015501098A1 (en) Antituberculous composition comprising oxazole compounds
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
EP1357124A4 (de) Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten
AU9025601A (en) Cephem compounds and esbl-detecting reagents containing the same
TW200505446A (en) Inhibitor of cox
MXPA05006450A (es) Nuevo derivado de 2,4-diamino-1,3,5-triazina.
DE60227655D1 (de) Pyrrolderivat
DK1433480T3 (da) Lægemiddel indeholdende pyrimidin-derivat
EP1557407A4 (de) Neue alpha-ketoamidderivate und deren verwendung
DK1140919T3 (da) 1,4-Disubstituerede cyclohexanderivater til behandling af depression
EP1489076A4 (de) Cyclisches hemiacetalderivat und dessen anwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1227096

Country of ref document: EP

REN Ceased due to non-payment of the annual fee